SEC Form 4 · accession 0001209191-15-072341
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Latham
Officer — Chief Scientific Officer
Period of report
Sep 24, 2015
Accepted (ET)
Sep 28, 2015 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 24, 2015 | M | 31,818 | $0.99 | A | 241,265 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.99 | Sep 24, 2015 | M | 31,818 | D | — | Apr 20, 2019 | Common Stock | 31,818 | 0 | D |
Explanation of responses
- F1The option is fully vested.